Academy Bans AI-Generated Actors and Scripts From Oscar Eligibility

The Academy of Motion Picture Arts and Sciences announced on May 2 that AI-generated performances and AI-written screenplays are ineligible for Academy Award consideration, effective for the 99th Awards. Human performers must be 'demonstrably' credited and consenting; scripts must be human-authored.

Abstract golden film reel dissolving into digital pixel noise, representing the boundary between human and AI performance in film.
Hollywood draws the line: the Oscar stage stays human — for now.

The Academy of Motion Picture Arts and Sciences announced on May 2 that AI-generated performances and AI-authored screenplays are no longer eligible for Academy Award consideration, effective for the 99th Academy Awards. Under the new rules, performances nominated in the Lead or Supporting Actor categories must be "credited in the film's legal billing and demonstrably performed by humans with their consent." Screenplays submitted for Original or Adapted Screenplay must be "human-authored." Films may still deploy AI tools in other production capacities — visual effects, color grading, sound design — and remain eligible in those respective categories. The Academy reserves the right to request documentation and verification of human authorship before confirming eligibility.

What the Rules Cover — and What They Leave Open

The eligibility rule is narrowly scoped to two categories: performance and screenplay authorship. An actor who uses an AI voice restoration tool for post-production audio repair — a practice already common in major studio films — would still be eligible, provided the underlying performance was delivered by a human. An actor whose voice and likeness were entirely synthesized by AI, with no original human performance as the source material, would not qualify, regardless of how realistic the result.

Two specific cases prompted the rule's timing. The AI "actress" Tilly Norwood — a fully synthetic character generated by a production company — appeared in a 2025 indie feature and was briefly considered for a Cannes debut-performance prize before industry backlash forced the festival to clarify its own policies. Separately, Val Kilmer's AI-recreated voice in a 2025 production received Screen Actors Guild consideration, creating legal uncertainty about what constitutes a "performance." The Academy's new language — "demonstrably performed by humans with their consent" — is designed to exclude synthetic recreations while preserving consent-based AI assistance that a living actor explicitly approved.

The Academy states it can audit entries and request supporting materials. What it does not yet specify is a standardized chain-of-documentation: no universal format exists today for studios to certify "this scene was performed by a human," and the absence of that standard will likely become the next flashpoint.

Why Hollywood's Guilds Made This Rule Inevitable

The rule institutionalizes what SAG-AFTRA and the Writers Guild of America negotiated in their 2023 strikes. Both guilds secured provisions requiring explicit consent for AI replicas of living actors and prohibiting studios from replacing human writers with AI-generated scripts under the cover of "AI-assisted" writing. What the guild contracts cover for employed members, the Academy rule now extends to the awards track — creating a consistent standard across the industry's two most visible frameworks.

Studios are already deploying "digital twin" contracts at scale: agreements in which an actor consents in advance to AI replication of their voice and likeness for specific defined purposes, typically limited to a production's duration. The Academy rule forces studios to maintain documentation separating consented-AI-enhancement from synthetic replacement, a distinction that will require new legal boilerplate and audit trails. Major productions that use AI for de-aging, voice repair, or on-set monitoring now have a compliance reason to build that documentation chain from day one.

The practical effect on streaming is limited: Netflix, Amazon, and Apple TV+ release content without Oscar aspirations for the majority of their catalog. A director building a fully AI-cast film for a streaming platform faces no Academy eligibility issue. The rule constrains only the prestige-track production environment where Oscar campaigns matter commercially.

Our Take

The Academy rule is symbolically significant and practically leaky. The "demonstrably performed by humans" standard is correct in principle but difficult to enforce without a verification infrastructure that doesn't currently exist as a mandatory industry format. The rule creates an incentive for studios to build that infrastructure — but it doesn't mandate one, and the Academy has no subpoena power.

The more consequential downstream effect is on SAG-AFTRA's 2027 contract negotiations. If the Academy's definition of "human performance" diverges from what the union negotiates into its next contract, studios will face two conflicting compliance standards simultaneously. Watch whether the guilds formally align their language with the Academy's in the next 12 months — that alignment would give the rule real teeth. In the meantime, the gray zone is enormous: hybrid productions that use AI for 40% of a performance but 60% human-originated material will need case-by-case rulings, and the Academy has not published a threshold or framework for those cases.

AI-generated actors and scripts are now ineligible for Oscars
TechCrunch documents the Academy's announcement, the Tilly Norwood and Val Kilmer precedents, and the specific language of the new eligibility rules.

Want every AI × Web3 signal the moment it breaks? Subscribe to the BlockAI News daily brief.

Keep Reading

SpaceX Eyes $119B 'Terafab' Chip Mega-Factory in Texas

SpaceX Eyes $119B 'Terafab' Chip Mega-Factory in Texas

SpaceX is evaluating an investment of up to $119 billion in a vertically integrated semiconductor manufacturing facility in Texas, according to reporting based on materials reviewed by Bloomberg. The proposed plant, internally referred to as "Terafab," would not merely assemble chips but would pursue end-to-end fabrication — spanning wafer production through advanced packaging — placing SpaceX in direct competition with established foundry giants at a scale that would rival TSMC's entire US expansion program.

What's New on the Table

The Terafab concept represents a significant strategic escalation

Read full story →

Stay Ahead of the Market

Daily AI & crypto briefings — straight to your inbox, your phone, and your timeline.